Significant progress has been made in the development of effective antiretroviral
drug regimens for the treatment of human immunodeficiency virus (HIV) disease.
Combinations of antiretroviral agents have been shown to decrease HIV RNA
levels to the limit of detection of current viral load assays in a majority
of patients for periods of months to years. These profound reductions in viral
load reflect significant decreases in viral replication and appear to limit
the emergence of resistant viral phenotypes, thereby promoting durable antiretroviral
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 24
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
For example, a trial of intravenous immunoglobulin in advanced human immunodeficiency infection...
The Rational Clinical Examination
Evidence Summary and Review 3
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.